The Top Six Ways Trump’s Policies Will Impact Pharmacies
We're still within the first 100 days of a new administration. What is happening, and what can you expect?
5. U.S. Representative Tom Price’s appointment as HHS Secretary
“As a member of the U.S. House of Representatives, Price (R-GA) has tended to mirror the approach of his Republican colleagues, which is to call for an easier drug approval process so that there would be more competition in the marketplace,” Hoey said.
In fact, at Price’s confirmation hearing, he signaled some willingness to look further into issues such as government negotiation of drug prices and reimportation, “a clear reflection that President Trump will naturally have the final say for his administration on these issues,” Hoey said.
Meanwhile, NACDS’ top priority is to translate Price’s high regard for affordability, accessibility, quality, innovation, responsiveness, and choices in health care reform into pro-patient and pro-pharmacy policies that “leverage the industry’s value while assuring its viability,” Anderson wrote. “Related issues that will demand substantial effort this year include advocating for appropriate reimbursement amid potential changes to the Affordable Care Act; for enactment of the pharmacist provider status legislation; for the Department of Defense’s implementation of the TRICARE pilot that was authorized late last year; and for remedies for the current application of [DIR] fees; among other issues.”